Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Alla GolomidovaWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.
Yuriy KupriyanovDepartment of Urology, Russian University of Medicine (ROSUNIMED), 2nd Botkinsky Proezd, 5 Bldg 20, 125284 Moscow, Russia.ORCID 0000-0002-5807-7591
Ruslan GabdrakhmanovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.
Marina GurkovaResearch and Production Center "MicroMir", Nizhny Kiselny Lane 5/23 Bldg 1, 107031 Moscow, Russia.
Eugene KulikovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.ORCID 0000-0002-9101-1543
Ilya BelalovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.ORCID 0000-0002-5447-4872
Viktoria UskevichResearch and Production Center "MicroMir", Nizhny Kiselny Lane 5/23 Bldg 1, 107031 Moscow, Russia.
Dmitry BespiatykhLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya ul. 1a, 119435 Moscow, Russia.ORCID 0000-0003-0867-5988
Maria LetarovaWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.ORCID 0000-0002-5330-6834
Alexander EfimovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.
Alexander KuznetsovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.ORCID 0000-0002-8016-3760
Egor ShitikovLopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Malaya Pirogovskaya ul. 1a, 119435 Moscow, Russia.ORCID 0000-0002-4865-6004
Dmitry PushkarDepartment of Urology, Russian University of Medicine (ROSUNIMED), 2nd Botkinsky Proezd, 5 Bldg 20, 125284 Moscow, Russia.
Andrey LetarovWinogradsky Institute of Microbiology, RC Biotechnology RAS, Prospekt 60-Letiya Oktyabrya 7 Bld. 2, 117312 Moscow, Russia.
Fedor ZurabovResearch and Production Center "MicroMir", Nizhny Kiselny Lane 5/23 Bldg 1, 107031 Moscow, Russia.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Isolation, Characterization, and Unlocking the Potential of Mimir124 Phage for Personalized Treatment of Difficult, Multidrug-Resistant Uropathogenic · full record | OpenQuestion